Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study
Brian G. Feagan, William J. Sandborn, Silvio Danese, Douglas C. Wolf, Wenzhong J. Liu, Steven Y. Hua, Neil Minton, Allan Olson, Geert D’Haens
Topics & Concepts
MedicineCrohn's diseaseInduction therapyBlinded studyClinical endpointProspective cohort studyInternal medicinePhysical therapyDiseaseClinical trialChemotherapyInflammatory Bowel DiseaseSphingolipid Metabolism and SignalingRheumatoid Arthritis Research and Therapies